Loading insider details...
Beta
Latest Form 4 (Aug 17, 2026): Grant/Award of 254,800 IMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | ImageneBio, Inc. (IMA) | Grant/Award | 254,800 | n/a |
| Jul 28, 2026 | ImageneBio, Inc. (IMA) | Exercise/Conversion | 38,376 | n/a |
| Mar 18, 2026 | ImageneBio, Inc. (IMA) | Grant/Award | 85,400 | n/a |
| Jul 31, 2025 | ImageneBio, Inc. (IMA) | Grant/Award | 460,515 | n/a |
| Jan 4, 2024 | Poseida Therapeutics, Inc. (PSTX) | Grant/Award | 250,000 | n/a |
| Mar 4, 2022 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 45,533 | n/a |
| Jun 15, 2021 | Atara Biotherapeutics, Inc. (ATRA) | Purchase | 2,021 | $29.3K |
| May 20, 2021 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 761 | $11.1K |
| Mar 3, 2021 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 35,021 | n/a |
| Mar 3, 2020 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 55,000 | n/a |